In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), ("Entera” or the "Company”) a leader in the ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

The connection between CVD and diabetes cannot be understated, as diabetes impacts CV health and heart conditions affect ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

Q4 2024 Earnings Call Transcript November 7, 2024 Operator: Hello and welcome to BD’s Fourth Quarter and Full Year Fiscal 2024 Earnings Call. At the request of BD, today’s call is being recorded and ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...